February, 2019

Press Release - Viedoc

Blueclinical Expands Business with Viedoc to Accelerate Bioequivalence and Early-Stage Clinical Studies

November, 2016

Blueclinical helped Labfit’s journey from Bench to Bedside

Blueclinical has helped another start-up on its from bench to bedside journey. Labfit has developed a medical device for chronic non-hypertrophic vulvar dermatosis and is currently undergoing clinical study in patients.

September, 2016

EC granted € 5M to a consortium in which Blueclinical is responsible for the regulatory plan and early clinical trials

Blueclinical is part of a H2020 Consortium which is working on an innovative approach to treat Rheumatoid Arthritis. It should reach phase I clinical trials in 2018.